Abstract:Objective To evaluate the feasibility of de tecting epidermal growth factor receptor (EGFR) mRNA by reverse transcription po lymerase chain reaction(RT-PCR)in peripheral blood of patients with breast cance r and to explore its significance. Methods RT-PCR assay w as applied to detect the expression of EGFR mRNA in the peripheral blood of 40 p atients with breast cancer and in 30 healthy donors. The result of EGFR mRNA was compared with that of known marker of circulating epithelial cells:CK-19. Results In peripheral blood from 30 healthy donors,none of EGF R mRNA was detected,but the positivity of CK19 mRNA expression was 26.7% (8/ 30) .In contrast ,EGFR mRNA was detected in 13 of 40(32.5%)patients with breast canc er,compared with healthy donors (P0.01),there was significant d ifference between the two groups. CK-19 mRNA was found in 14 of 40(35.0%), compa red with healthy donors (P0.05) and there was no statistical di fference. On the other hand, the expression of EGFR was observed in 25(62.5%) of tumor tissues by immunohistochemistry. We found that all patients who expressed EGFR mRNA in peripheral blood were also expressing EGFR in primary tumors. Pati ents with a high expression of EGFR in tumoral breast tissues display high expre ssion of EGFR in peripheral blood as well(P0.01). EGFR mRNA w as expressed in 5 of 26(19.2%) breast cancer patients without any treatments bef ore, but the positivity for EGFR mRNA expression was 57.1% (8/ 14) in breast can cer patients who have received treatments before. There is significant differenc e between two groups above (P0.05). Expression of EGFR mRNA was detected in 1of 6 (16.7%) metastatic breast cancer patients who have received P aclitaxel involved salvage chemotherapy, however, the positivity for EGFR mRNA e xpression was 87.5% (7/ 8) in them who have never received Paclitaxel contained salvage chemotherapy, there was significant difference between two groups ( P0.05). Conclusion CK-19 mR NA showed no dia gnostic value as marker of circulating tumor cells in breast cancers. However, E GFR mRNA in blood may be a useful marker of circulating tumor cells in breast ca ncers. Detecting EGFR mRNA in peripheral blood of patients with breast cancer us ing RT-PCR can be used as a prognostic indicator. Paclitaxel may reduce the risk of relapse and metastasis of breast cancer.

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-polymerase Chain Reaction in Patients with Breast Cancer

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-Polymerase Chain Reaction in Patients with Colorectal Cancer

Application of Immunomagnetic Separation in Combination with Fluorescence Quantitative RT-PCR for Detecting Micrometastasis in Circulation in Patients with Prostate Cancer

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF CYTOKERATIN 20 mRNA IN CENTRAL VEIN BLOOD OF PATIENTS WITH GASTRIC CANCER BY RT-PCR

Detection of SBEM-mRNA in Peripheral Blood of Patients with Breast Cancer and Its Clinical Significance

Detection of SBEM-mRNA level in peripheral blood of patients with breast cancer and its clinical significance

Expressions of Hmam Mrna and CD44V6 Mrna in Breast Cancer

Human Mammaglobin: a Superior Marker for Reverse-Transcriptase PCR in Detecting Circulating Tumor Cells in Breast Cancer Patients

[Mammaglobin Mrna Measurement in the Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients].

Detection and Clinical Significance of Hmam Mrna-Positive Circulating Tumor Cells in Early Breast Cancer

Combined Detection of Breast Cancer Micrometastases in the Lymph Nodes and Bone Marrow Using Reverse-Transcriptase Chain Reaction and Southern Hybridization

Comparative Study of Detection of Epidermal Growth Factor Receptor and Cytokeratin - 19 Mrna in Peripheral Blood of Breast Cancer Patients by Reverse Transcription Polymerase Chain Reaction

Detection of Cytokeratin 19 (CK19) Mrna and Human Papillomavirus Type 16 (HPV16) Mrna in Peripheral Blood of Cervical Cancer Patients and Its Significance

[Expression of Small Breast Epithelial Mucin Mrna in Peripheral Blood of Breast Cancer Patients and Its Clinical Significance].

Sensitive and Specific Detection of Micrometastasis of Hepatic Carcinoma in Peripheral Blood by Immunomagnetic Nanobeads Polymerase Chain Reaction

Detection of Micrometastases in the Axillary Lymph Nodes in Patients with Breast Cancer by Reverse Transcriptase Polymerase Chain Reaction and Southern Hybridization

Circulating Micrornas As Specific Biomarkers for Breast Cancer Detection

The Detection of Micrometastases in the Peripheral Blood of Patients with Breast Cancer for Hsbem Mrna and CD44V6 Mrna

Expression and Clinical Significance of Stathmin in Human Breast Carcinomas

Template-ready PCR Method for Detection of Human Telomerase Reverse Transcriptase Mrna in Sputum

The value of combined detection of PCA3 mRNA and PSA mRNA in peripheral blood of patients with prostate cancer